Insights: Policy

Medicare Part D Premium Stabilization Demonstration

The Trump administration announced it will terminate the Part D premium stabilization demonstration after 2026.

Medicaid Payments (OBBBA, Provider Taxes)

CMS released a proposed rule implementing OBBBA’s new restrictions on states’ use of health care provider taxes to finance Medicaid. Comments are due September 21.

CLARITY Act (Crypto Market Structure)

Bipartisan negotiations on the CLARITY Act (crypto market structure legislation) remain intense, particularly on the three priority issues that need to be resolved prior to passage. Sen. Tillis (R-NC) has been working with Sen. Gallego (D-AZ) on a new bipartisan proposal for an ethics provision to the bill that has reportedly been submitted to...

Government Funding/Shutdown, CR, Defense/Farmer Supplemental

The House passed a “continuing resolution (CR)” to extend current funding levels for government operations from the beginning of FY27 on 10/1 through 12/4. Key players on the Senate Appropriations Committee (e.g., Chair Collins (R-ME), Ranking Member Murray (D-WA), Sen. Schatz (D-HI), others) are signaling that negotiations on their version of a...

Bipartisan legislation intended to lower the regulatory barriers to developing and using biosimilars is advancing in both chambers. The House Energy & Commerce (E&C) Committee approved the Expedited Access to Biosimilars Act and the Biosimilar Red Tape Elimination Act this week (as part of a 45-0 vote on the broader Lower Costs, More Transparency...

Healthcare Price Transparency

House and Senate lawmakers are advancing proposals to increase healthcare price transparency. On July 21, the House Energy & Commerce (E&C) Committee unanimously approved the Lower Costs, More Transparency Act (H.R. 9393), along with several narrower transparency measures. And on July 22, the Senate Health, Education, Labor, & Pensions (HELP)...